MLICM
CSII

Metropolitan Life Insurance Company (MetLife)’s Cardiovascular Systems, Inc. CSII Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,212
Closed -$43.9K – 2557
2023
Q1 		$43.9K Sell
2,212
-514
-19% -$8.88K ﹤0.01% 1457
2022
Q4 		$37.1K Hold
2,726
– – ﹤0.01% 1656
2022
Q3 		$37.8K Hold
2,726
– – ﹤0.01% 1645
2022
Q2 		$39.1K Hold
2,726
– – ﹤0.01% 1654
2022
Q1 		$61.6K Sell
2,726
-8,987
-77% -$174K ﹤0.01% 1473
2021
Q4 		$220K Hold
11,713
– – ﹤0.01% 1963
2021
Q3 		$385K Hold
11,713
– – 0.01% 1622
2021
Q2 		$500K Buy
11,713
+779
+7% +$30.5K 0.01% 1525
2021
Q1 		$419K Sell
10,934
-380
-3% -$16.2K 0.01% 1524
2020
Q4 		$495K Hold
11,314
– – 0.01% 1357
2020
Q3 		$445K Buy
11,314
+999
+10% +$32.3K 0.01% 1292
2020
Q2 		$325K Hold
10,315
– – 0.01% 1504
2020
Q1 		$363K Sell
10,315
-1,107
-10% -$46.7K 0.01% 1237
2019
Q4 		$555K Hold
11,422
– – 0.01% 1261
2019
Q3 		$543K Hold
11,422
– – 0.01% 1234
2019
Q2 		$490K Hold
11,422
– – 0.01% 1314
2019
Q1 		$442K Hold
11,422
– – 0.01% 1382
2018
Q4 		$325K Hold
11,422
– – 0.01% 1497
2018
Q3 		$447K Hold
11,422
– – 0.01% 1450
2018
Q2 		$369K Hold
11,422
– – 0.01% 1524
2018
Q1 		$250K Hold
11,422
– – ﹤0.01% 1756
2017
Q4 		$271K Sell
11,422
-10,756
-48% -$271K ﹤0.01% 1708
2017
Q3 		$624K Hold
22,178
– – ﹤0.01% 1535
2017
Q2 		$715K Buy
22,178
+269
+1% +$8.2K ﹤0.01% 1446
2017
Q1 		$619K Sell
21,909
-532
-2% -$14.1K ﹤0.01% 1516
2016
Q4 		$543K Hold
22,441
– – ﹤0.01% 1678
2016
Q3 		$533K Hold
22,441
– – ﹤0.01% 1668
2016
Q2 		$412K Hold
22,441
– – ﹤0.01% 1823
2016
Q1 		$233K Hold
22,441
– – ﹤0.01% 2082
2015
Q4 		$339K Hold
22,441
– – ﹤0.01% 1884
2015
Q3 		$355K Buy
22,441
+91
+0.4% +$2.29K ﹤0.01% 1868
2015
Q2 		$591K Buy
22,350
+1,859
+9% +$60.1K ﹤0.01% 1634
2015
Q1 		$800K Sell
20,491
-1,211
-6% -$41.7K 0.01% 1331
2014
Q4 		$653K Buy
21,702
+1,527
+8% +$43.7K ﹤0.01% 1578
2014
Q3 		$477K Hold
20,175
– – ﹤0.01% 1756
2014
Q2 		$629K Hold
20,175
– – ﹤0.01% 1663
2014
Q1 		$641K Hold
20,175
– – ﹤0.01% 1629
2013
Q4 		$692K Buy
20,175
+2,165
+12% +$63K ﹤0.01% 1584
2013
Q3 		$361K Hold
18,010
– – ﹤0.01% 1978
2013
Q2 		$382K Buy
+18,010
New +$350K ﹤0.01% 1878

Other funds holding CSII

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CSII Position: Q2 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cardiovascular Systems, Inc. (CSII) in Q2 2023, closing a stake of 2,212 shares — an estimated $43.9K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CSII in Q2 2013 and held it in 40 quarters. The position peaked at $800K in Q1 2015. 2 funds tracked by Wall St. Rank hold CSII as of Q2 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cardiovascular Systems, Inc. position as of Q2 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,212 Cardiovascular Systems, Inc. shares in Q2 2023, an estimated $43.9K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cardiovascular Systems, Inc. in Q2 2013 and held it in 40 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cardiovascular Systems, Inc. position peaked at $800K in Q1 2015.
  • 2 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q2 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2023, filed 10 Aug 2023.